Sun Pharmaceutical Industries Ltd., a large generic drug manufacturer founded and controlled by Indian billionaire Dilip Shanghvi, has recruited a new general counsel from Roivant Sciences Ltd.
Erik Zwicker, the new in-house legal chief at Mumbai-based Sun Pharma, spent the past year as acting general counsel and head of legal at Roivant, which was founded in 2014 by CEO Vivek Ramaswamy, a Yale Law School graduate and former hedge fund manager.
Roivant is currently working on a potential antibody treatment for Covid-19. The company, which is backed by Japan’s SoftBank Group Corp., elevated Zwicker to interim legal head in ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.